PW Medtech Group Ltd.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: KYG7306W1087
HKD
1.33
-0.02 (-1.48%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

Company's ability to service its debt is strong with a healthy EBIT to Interest (avg) ratio of 69.46

 
2

Healthy long term growth as Net Sales has grown by an annual rate of 23.04%

 
3

Negative results in Dec 24

4

With ROE of 4.97%, it has a Attractive valuation with a 0.52 Price to Book Value

5

Consistent Returns over the last 3 years

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

HKD 2,131 Million ()

stock-summary
P/E

11.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

1.47%

stock-summary
Debt Equity

-0.44

stock-summary
Return on Equity

4.60%

stock-summary
Price to Book

0.49

Revenue and Profits:
Net Sales:
(Quarterly Results - )
Net Profit:
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-11.92%
0%
-11.92%
6 Months
25.47%
0%
25.47%
1 Year
30.39%
0%
30.39%
2 Years
77.33%
0%
77.33%
3 Years
114.52%
0%
114.52%
4 Years
26.67%
0%
26.67%
5 Years
-40.09%
0%
-40.09%

PW Medtech Group Ltd. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
23.04%
EBIT Growth (5y)
42.60%
EBIT to Interest (avg)
69.46
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.42
Sales to Capital Employed (avg)
0.13
Tax Ratio
16.20%
Dividend Payout Ratio
92.54%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
2.88%
ROE (avg)
8.97%
Valuation key factors
Factor
Value
P/E Ratio
11
Industry P/E
Price to Book Value
0.52
EV to EBIT
2.89
EV to EBITDA
1.54
EV to Capital Employed
0.17
EV to Sales
0.50
PEG Ratio
NA
Dividend Yield
1.42%
ROCE (Latest)
5.96%
ROE (Latest)
4.97%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
No Trend
No Trend
OBV
No Trend
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by PW Medtech Group Ltd."
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'23",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2023 is 19.49% vs 90.86% in Dec 2022",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2023 is 51.17% vs -83.17% in Dec 2022",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'23",
        "Dec'22",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "746.00",
          "val2": "624.30",
          "chgp": "19.49%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "268.40",
          "val2": "165.20",
          "chgp": "62.47%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.20",
          "val2": "0.50",
          "chgp": "-60.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.10",
          "val2": "-0.30",
          "chgp": "66.67%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "226.60",
          "val2": "149.90",
          "chgp": "51.17%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "214.30%",
          "val2": "118.30%",
          "chgp": "9.60%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Annual Results Snapshot (Consolidated) - Dec'23stock-summary
Dec'23
Dec'22
Change(%)
Net Sales
746.00
624.30
19.49%
Operating Profit (PBDIT) excl Other Income
268.40
165.20
62.47%
Interest
0.20
0.50
-60.00%
Exceptional Items
-0.10
-0.30
66.67%
Consolidate Net Profit
226.60
149.90
51.17%
Operating Profit Margin (Excl OI)
214.30%
118.30%
9.60%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2023 is 19.49% vs 90.86% in Dec 2022

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2023 is 51.17% vs -83.17% in Dec 2022

stock-summaryCompany CV
About PW Medtech Group Ltd. stock-summary
stock-summary
PW Medtech Group Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available